AIDS. Promote HIV chemoprophylaxis research, don't prevent it

Science. 2005 Sep 30;309(5744):2170-1. doi: 10.1126/science.1116204.
No abstract available

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / economics
  • Adenine / therapeutic use
  • Africa
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / economics
  • Anti-HIV Agents / therapeutic use*
  • Asia
  • Community Participation
  • Controlled Clinical Trials as Topic* / standards
  • Counseling
  • Developing Countries
  • Drug Costs
  • Female
  • HIV Infections / prevention & control*
  • Health Services Accessibility
  • Humans
  • Latin America
  • Male
  • Organophosphonates / adverse effects
  • Organophosphonates / economics
  • Organophosphonates / therapeutic use*
  • Patient Selection
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Tenofovir
  • Adenine